A new duet in cancer biology: AMPK the typical and UBE2O the atypical

Citations

WEB OF SCIENCE

8
Citations

SCOPUS

7

초록

Ubiquitin-conjugating enzyme E2O (UBE2O) is upregulated in human cancers. We have demonstrated that genetic deletion or pharmacological blockade of UBE2O reduces tumorigenesis through inhibiting the mammalian target of rapamycin complex 1-hypoxia-inducible factor 1-alpha pathway. Critically, UBE2O targets adenosine monophosphate (AMP)-activated protein kinase-alpha 2 (AMPK alpha 2) for ubiquitination and degradation. We thus suggest the UBE2O-AMPK alpha 2 axis as a potential therapeutic target for cancer.

키워드

AMPKAMPK alpha 2arsenitebreast cancercancer metabolismHIF1 alphamTORprostate cancerUBE2OubiquitinationTUMOR-SUPPRESSORUBIQUITINATION
제목
A new duet in cancer biology: AMPK the typical and UBE2O the atypical
저자
Vila, Isabelle K.Song, Su JungSong, Min Sup
DOI
10.1080/23723556.2017.1304846
발행일
2017
유형
Editorial Material
저널명
MOLECULAR & CELLULAR ONCOLOGY
4
3